Clinical risk factors for vasculo-placental disorders: results from a prospective case-control study nested in HEMOTHEPP French cohort study.

[1]  S. Maguire,et al.  Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis. , 2020, Seminars in arthritis and rheumatism.

[2]  E. Carreras,et al.  Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial , 2020, Fetal Diagnosis and Therapy.

[3]  C. D. de Groot,et al.  Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism , 2020, Hypertension.

[4]  K. Bennett,et al.  Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population , 2019, Journal of thrombosis and haemostasis : JTH.

[5]  I. Pantic,et al.  The association between IUGR and maternal inherited thrombophilias , 2018, Medicine.

[6]  N. Uldbjerg,et al.  Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial. , 2018, Thrombosis research.

[7]  A. David,et al.  The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. , 2017, American journal of obstetrics and gynecology.

[8]  A. Fauchais,et al.  [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?] , 2018, La Revue de medecine interne.

[9]  E. Polard,et al.  [Aspirin: Indications and use during pregnancy]. , 2017, La Revue de medecine interne.

[10]  K. Aagaard,et al.  Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia , 2017, American journal of obstetrics and gynecology.

[11]  Nicola Persico,et al.  Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia , 2017, The New England journal of medicine.

[12]  S. Kane,et al.  Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial , 2017, American journal of obstetrics and gynecology.

[13]  K. Nicolaides,et al.  The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.

[14]  J. Gris,et al.  Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.

[15]  P. Robillard,et al.  Pre-eclampsia and preterm birth in Reunion Island: a 13 years cohort-based study. Comparison with international data , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[16]  L. Novack,et al.  LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia , 2016, Thrombosis and Haemostasis.

[17]  C. Abheiden,et al.  Does low‐molecular‐weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early‐onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results , 2016, BJOG : an international journal of obstetrics and gynaecology.

[18]  G. Maruotti,et al.  Diagnosis of placental abruption: a legal issue for physicians , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[19]  J. Blacher,et al.  [Hypertension and pregnancy. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology]. , 2016, Presse medicale.

[20]  C. Flamant,et al.  Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. , 2015, European journal of obstetrics, gynecology, and reproductive biology.

[21]  E. Horváth-Puhó,et al.  Preconception venous thromboembolism and placenta‐mediated pregnancy complications , 2015, Journal of thrombosis and haemostasis : JTH.

[22]  N. Smith,et al.  Association Between Newborn Birth Weight and the Risk of Postpartum Maternal Venous Thromboembolism: A Population-Based Case–Control Study , 2015, Circulation.

[23]  J. Douketis,et al.  Factors that predict thrombosis in relatives of patients with venous thromboembolism. , 2014, Blood.

[24]  F. Granath,et al.  Birth Outcomes in Women with Inflammatory Bowel Disease: Effects of Disease Activity and Drug Exposure , 2014, Inflammatory bowel diseases.

[25]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[26]  A. Gaudineau [Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.

[27]  J. Sundquist,et al.  Venous thromboembolism does not share strong familial susceptibility with pre‐eclampsia/eclampsia: a nationwide family study in Sweden , 2013, BJOG : an international journal of obstetrics and gynaecology.

[28]  A. Ego [Definitions: small for gestational age and intrauterine growth retardation]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.

[29]  M. Petri,et al.  Management of pregnancy in systemic lupus erythematosus , 2012, Nature Reviews Rheumatology.

[30]  P. Mortensen EPIDEMIOLOGY , 2012, Schizophrenia Research.

[31]  E. Ferrazzi,et al.  Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study , 2012, Journal of Maternal-Fetal & Neonatal Medicine.

[32]  G. Leone,et al.  In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband , 2011, Thrombosis and Haemostasis.

[33]  A. Many,et al.  Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[34]  C. Gordon,et al.  Managing pregnancy in inflammatory rheumatological diseases , 2011, Arthritis research & therapy.

[35]  G. Hoff,et al.  Risk factors for recurrent small-for-gestational-age birth. , 2010, American journal of perinatology.

[36]  K. Haram,et al.  The HELLP syndrome: Clinical issues and management. A Review , 2009, BMC pregnancy and childbirth.

[37]  J. Dungan Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data , 2008 .

[38]  P. Langhorne,et al.  Thrombophilia in pregnancy: a systematic review , 2006, British journal of haematology.

[39]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[40]  M. Rodger,et al.  A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. , 2005, American journal of obstetrics and gynecology.

[41]  Yun-fei Gao,et al.  [Effect of heparin on fetal growth restriction]. , 2004, Zhonghua fu chan ke za zhi.

[42]  T. Leet,et al.  Body Mass Index Change Between Pregnancies and Small for Gestational Age Births , 2004, Obstetrics and gynecology.

[43]  H. Honest,et al.  Aspirin for Prevention of Preeclampsia in Women With Historical Risk Factors: A Systematic Review , 2003, Obstetrics and gynecology.

[44]  D. Roberts,et al.  How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[45]  A. Many,et al.  Pathologic Features of the Placenta in Women With Severe Pregnancy Complications and Thrombophilia , 2001, Obstetrics and gynecology.

[46]  A. Kaider,et al.  Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[47]  F. Kraus,et al.  Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. , 1999, Human pathology.

[48]  J N Martin,et al.  The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. , 1999, American journal of obstetrics and gynecology.

[49]  O. Thorarensen,et al.  Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis , 1997, Annals of neurology.

[50]  K. Ward,et al.  Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. , 1997, American journal of obstetrics and gynecology.